Format

Send to

Choose Destination
See comment in PubMed Commons below
Semin Neurol. 2016 Feb;36(1):64-72. doi: 10.1055/s-0036-1571847. Epub 2016 Feb 11.

Botulinum Toxin Treatment of Spasticity in Adults and Children.

Author information

1
Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.
2
Department of Diagnostic radiology, Yale University School of Medicine, New Haven, Connecticut.

Abstract

Spasticity is a frequent symptom in stroke, multiple sclerosis, cerebral or spinal trauma, and cerebral palsy that affects and disables a large number of adults and children. In this review, we discuss the pathophysiology and nonpharmacologic and pharmacologic treatments of spasticity with emphasis on the role of botulinum neurotoxins (BoNTs). The world literature is reviewed on double-blind and placebo-controlled clinical trials reporting safety and efficacy of BoNT treatment in adult spasticity and spasticity of children with cerebral palsy. The evidence for efficacy is presented from recommendations of the Assessment and Therapeutics subcommittee of the American Academy of Neurology. A technical section describes the techniques and recommended doses of BoNTs in spasticity.

PMID:
26866498
DOI:
10.1055/s-0036-1571847
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Georg Thieme Verlag Stuttgart, New York
    Loading ...
    Support Center